Exploring acemannan-loaded nanogel formulation for the treatment of IMQ-induced psoriasis-like inflammation: In vitro characterization and in vivo efficacy assessment
- 29 January 2025
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 148, 114064
Abstract
No abstract availableKeywords
Funding Information
- King Saud University
This publication has 37 references indexed in Scilit:
- Preparation and characterization of solid lipid nanoparticles encapsulated noscapine and evaluation of its protective effects against imiquimod-induced psoriasis-like skin lesionsBiomedicine & Pharmacotherapy, 2023
- Evidence on the therapeutic role of thiolutin in imiquimod‐induced psoriasis‐like skin inflammation in miceImmunity, Inflammation and Disease, 2023
- Decreased Imiquimod-Induced Psoriasis-Like Skin Inflammation in a Novel MvdF250S/+ Knock-In Mouse ModelInflammation, 2023
- Dynamic trafficking patterns of IL-17-producing γδ T cells are linked to the recurrence of skin inflammation in psoriasis-like dermatitisEBioMedicine, 2022
- Perillyl alcohol inhibits keratinocyte proliferation and attenuates imiquimod-induced psoriasis like skin-inflammation by modulating NF-κB and STAT3 signaling pathwaysInternational Immunopharmacology, 2022
- Losartan ointment attenuates imiquimod-induced psoriasis-like inflammationInternational Immunopharmacology, 2021
- Galangin ameliorates Imiquimod-Induced psoriasis-like skin inflammation in BALB/c mice via down regulating NF-κB and activation of Nrf2 signaling pathwaysInternational Immunopharmacology, 2021
- Improved imiquimod-induced psoriasis like dermatitis using microneedles in miceEuropean Journal of Pharmaceutics and Biopharmaceutics, 2021
- Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1/Th17 cell population and keratinocyte activationInternational Immunopharmacology, 2020
- Advancement in nanogel formulations provides controlled drug releaseInternational Journal of Pharmaceutics, 2020